Renal cell carcinoma: 400 mg PO q12hr. Hepatocellular carcinoma: 400 mg PO q12hr. Thyroid cancer: 400 mg PO q12hr. Dose reduction for skin toxicity: 600 mg/day first, then 200 mg q12hr
WHO CNS grade 2-4 tumors found in adult brain tissue. No identifiable border between tumor and normal brain tissue. Diagnosed based on IDH mutation and absence of 1p19q codeletion. Median age of diagnosis is 36 years for grades 2-3, 38 for grade 4
BCC is the most common skin cancer, accounting for less than 0.1% of cancer deaths. Tumors typically appear on sun-exposed skin, rarely metastasizing. Most common on face, head, and neck (85%), with 15% on trunk and extremities
Oligodendrogliomas originate from brain oligodendrocytes and occur in both adults and children. Most commonly found in frontal lobe, with seizures occurring in 50-80% of cases. Causes unknown, but linked to viral factors and NJDS gene mutations
AHCC is a mushroom extract containing alpha-1,4-glucan oligosaccharides. Used to enhance immune system and treat various conditions
Fam-trastuzumab deruxtecan-nxki is a HER2-directed antibody-drug conjugate. Preservative-free lyophilized vial for IV infusion. Contains humanized anti-HER2 IgG1 antibody and topoisomerase I inhibitor DXd